HMPL-453 in Advanced Malignant Mesothelioma

Status Recruiting

Clinical Trial Summary

This is a phase II, single arm, multicenter and open-label study to evaluate the efficacy, safety and pharmacokinetic of HMPL-453 in patient with advanced Malignant Mesothelioma

Clinical Trial Description

Histologically confirmed patients with advanced malignant mesothelioma that who was failure of the first -line systemic therapy ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04290325
Study type	Interventional
Source	Hutchison Medipharma Limited
Contact	Wenjuan Ding
Phone	+8602120671806
Email	Wenjuand@hmplglobal.com
Status	Recruiting
Phase	Phase 2
Start date	December 30, 2019
Completion date	March 17, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00025207` - Gefitinib in Treating Patients With Malignant Mesothelioma	Phase 2
Terminated	`NCT00028782` - EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer	N/A
Completed	`NCT00027703` - Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma	Phase 2
Completed	`NCT00243074` - S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery	Phase 2
Completed	`NCT01126346` - Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	N/A
Completed	`NCT00039182` - Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung	Phase 2
Withdrawn	`NCT01325753` - Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body	N/A
Completed	`NCT00459862` - Pazopanib in Treating Patients With Malignant Pleural Mesothelioma	Phase 2
Completed	`NCT00365053` - PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery	Phase 2
Completed	`NCT00392444` - Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma	Phase 2
Completed	`NCT00309946` - Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery	Phase 2
Completed	`NCT00030498` - Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction	Phase 1
Withdrawn	`NCT01105390` - AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma	Phase 2